NCT04212221 2024-07-23MGD013 Monotherapy and Combination With Brivanib Dose Escalation and Expansion Study in Advanced Liver Cancer PatientsZai Lab (Hong Kong), Ltd.Phase 1/2 Terminated89 enrolled 23 charts